Figure | Mice per group | Total no. | From cohort(s) | Age at analysis | |
---|---|---|---|---|---|
Longevity | |||||
2B | NTG, 111 | 366 mice | A–H | 3 weeks to 12.5 months | |
hAPP, 67 | |||||
KL, 110 | |||||
hAPP/KL, 78 | |||||
EEG | |||||
2D | NTG, 3 | 21 mice | B | 2–3.5 months | |
KL, 4 | |||||
hAPP, 7 | |||||
hAPP/KL, 7 | |||||
Behavior | |||||
Water maze | 3A–C | NTG, 14 | 63 mice | B, C | 4–7 months |
KL, 14 | |||||
hAPP, 18 | |||||
hAPP/KL, 17 | |||||
Novel object | 3D | NTG, 10 | 45 mice | C | 5–8 months |
KL, 11 | |||||
hAPP, 12 | |||||
hAPP/KL, 12 | |||||
Passive avoidance | 3E | NTG, 23 | 72 mice | C | 5–8 months |
KL, 21 | |||||
hAPP, 15 | |||||
hAPP/KL, 13 | |||||
Open field, elevated plus maze | 3F, G | NTG, 24 | 81 mice | C | 4–7 months |
KL, 21 | |||||
hAPP, 20 | |||||
hAPP/KL, 16 | |||||
Biochemistry/histology | |||||
Western | 1 | NTG, 10 | 23 mice | D | 5–7 months |
hAPP, 13 | |||||
Western | 2A, 6B–F, 7B, C | NTG, 14–15 | 43–45 mice | E | 3 months |
KL, 13 | |||||
hAPP, 7–8 | |||||
hAPP/KL, 9 | |||||
Westerns, Aβ ELISA | 4B, E, K, L | hAPP, 7–8 | 15–17 mice | E | 3 months |
hAPP/KL, 8–9 | |||||
Aβ oligomer ECL assay | 4F | hAPP, 4 | 8 mice | F | 3–4.5 months |
hAPP/KL, 4 | |||||
Western | 4D | hAPP, 4 | 8 mice | F | 3–4.5 months |
hAPP/KL, 4 | |||||
Immunohistochemistry | 4H, J | hAPP, 12–13 | 21 mice | C | 10–12.5 months |
hAPP/KL, 8–9 | |||||
Immunohistochemistry | 5B, C | NTG, 25 | 75 mice | C | 10–12.5 months |
KL, 27 | |||||
hAPP, 14 | |||||
hAPP/KL, 9 | |||||
Electrophysiology | |||||
EPSP (LTP) | 8A, B | NTG 3 slices/3 mice | 23 slices, 16 mice | G | 3.5–4.5 months |
KL 6 slices/5 mice | |||||
hAPP 7 slices/5 mice | |||||
hAPP/KL 7 slices/3 mice | |||||
fEPSP (I/O curves) | 8C | NTG 9 slices/3 mice | 39 slices, 16 mice | H | 3.5–4.5 months |
KL 10 slices/5 mice | |||||
hAPP 9 slices/5 mice | |||||
hAPP/KL 11 slices/3 mice |
Cohorts are independent groups of mice, some or all of which were analyzed at one or more time points/ages in one or more paradigms.